Crossmark

Niacin‐mediated Tace activation ameliorates <scp>CMT</scp> neuropathies with focal hypermyelination

Crossref DOI link: https://doi.org/10.15252/emmm.201606349

Published Online: 2016-10-31

Published Print: 2016-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Bolino, Alessandra https://orcid.org/0000-0002-8980-4878
Piguet, Françoise

Alberizzi, Valeria

Pellegatta, Marta

Rivellini, Cristina

Guerrero‐Valero, Marta

Noseda, Roberta

Brombin, Chiara

Nonis, Alessandro

D'Adamo, Patrizia

Taveggia, Carla

Previtali, Stefano Carlo
Funding

Funding for this research was provided by:

Fondazione Telethon (GPP10007D)

Fondazione Telethon (GGP12017)

Fondazione Telethon (GGP15012A)

Fondazione Telethon (GPP10007)

Fondazione Telethon (GGP15012)

Fondazione Telethon (GGP15012B)

Fondazione Telethon (GGP12024)

Fondazione Telethon (GPP10007B)

Association Française contre les Myopathies (16040)

Association Française contre les Myopathies (16922)

Association Française contre les Myopathies (15‐18518)

Ministero della Salute (RF‐2011‐02347127)

European Commission (ERA‐net 2015 CMT‐NRG)

European Commission (PCOFUND‐GA‐2010‐267264 INVEST)
License Information

Version of Record valid from 2016-10-31
More Information

Publication History

Received: 2016-02-27

Accepted: 2016-10-04

Published: 2016-10-31